Frequency and Outcome of Olfactory Impairment and Sinonasal Involvement in Hospitalized Patients with COVID-19

Overview

Journal Neurol Sci

Specialty Neurology

Date 2020 Jul 14

PMID 32656713

Citations 29

Authors

Maryam Jalessi

Mitra Barati

Mohammad Rohani

Elahe Amini

Anis Ourang

Zahra Azad

Farideh Hosseinzadeh

Francesco Cavallieri

Reza Ghadirpour

Franco Valzania

Corrado Iaccarino

Arman Ahmadzadeh

Mohammad Farhadi

Affiliations

Soon will be listed here.

Abstract

Background: Olfactory dysfunction has shown to accompany COVID-19. There are varying data regarding the exact frequency in the various study population. The outcome of the olfactory impairment is also not clearly defined.

Objective: To find the frequency of olfactory impairment and its outcome in hospitalized patients with positive swab test for COVID-19.

Methods: This is a prospective descriptive study of 100 hospitalized COVID-19 patients, randomly sampled, from February to March 2020. Demographics, comorbidities, and laboratory findings were analyzed according to the olfactory loss or sinonasal symptoms. The olfactory impairment and sinonasal symptoms were evaluated by 9 Likert scale questions asked from the patients.

Results: Ninety-two patients completed the follow-up (means 20.1 (± 7.42) days). Twenty-two (23.91%) patients complained of olfactory loss and in 6 (6.52%) patients olfactory loss was the first symptom of the disease. The olfactory loss was reported to be completely resolved in all but one patient. Thirty-nine (42.39%) patients had notable sinonasal symptoms while rhinorrhea was the first symptom in 3 (3.26%). Fifteen patients (16.3%) had a taste impairment. Patients with sinonasal symptoms had a lower age (p = 0.01). There was no significant relation between olfactory loss and sinonasal symptoms (p = 0.07).

Conclusions: Sudden olfactory dysfunction and sinonasal symptoms have a considerable prevalence in patients with COVID-19. No significant association was noted between the sinonasal symptoms and the olfactory loss, which may suggest that other mechanisms beyond upper respiratory tract involvement are responsible for the olfactory loss.

Citing Articles

Olfactory dysfunction in COVID-19; Self-report or olfactory dysfunction test?.

Sahebalzamani E, Alijanpour S, Saadat P Caspian J Intern Med. 2024; 16(1):37-46.

PMID: 39619752 PMC: 11607109. DOI: 10.22088/cjim.16.1.37.

Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis.

Hannum M, Koch R, Ramirez V, Marks S, Toskala A, Herriman R Chem Senses. 2023; 48.

PMID: 38100383 PMC: 11320609. DOI: 10.1093/chemse/bjad043.

Olfactory dysfunction among patients with COVID-19.

Alkholaiwi F, Altamimi A, Almalki H, Almughaiseeb F, Alsubaie S, Alsayahi H Saudi Med J. 2023; 44(11):1085-1103.

PMID: 37926445 PMC: 10712775. DOI: 10.15537/smj.2023.44.11.20230264.

Olfactory impairment in COVID-19: Two methods for the assessment of olfactory function.

Tao A, Shi L, Wang Y, Duo Z, Zhao X, Mao H Heliyon. 2023; 9(3):e14104.

PMID: 36890807 PMC: 9979703. DOI: 10.1016/j.heliyon.2023.e14104.

The Impact of COVID-19 Infection on Miscellaneous Inflammatory Disorders of the Gastrointestinal Tract.

Cappell M, Tobi M, Friedel D Gastroenterol Clin North Am. 2023; 52(1):115-138.

PMID: 36813420 PMC: 9537253. DOI: 10.1016/j.gtc.2022.10.002.

References

Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L . Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020; 71(15):889-890. PMC: 7184514. DOI: 10.1093/cid/ciaa330. View

Flanagan C, Wise S, DelGaudio J, Patel Z . Association of decreased rate of influenza vaccination with increased subjective olfactory dysfunction. JAMA Otolaryngol Head Neck Surg. 2015; 141(3):225-8. DOI: 10.1001/jamaoto.2014.3399. View

Hwang C . Olfactory neuropathy in severe acute respiratory syndrome: report of A case. Acta Neurol Taiwan. 2006; 15(1):26-8. View

Lechien J, Chiesa-Estomba C, De Siati D, Horoi M, Le Bon S, Rodriguez A . Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020; 277(8):2251-2261. PMC: 7134551. DOI: 10.1007/s00405-020-05965-1. View

Lim W, van der Eerden M, Laing R, Boersma W, Karalus N, Town G . Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003; 58(5):377-82. PMC: 1746657. DOI: 10.1136/thorax.58.5.377. View

Trotier D, Bensimon J, Herman P, Tran Ba Huy P, Doving K, Eloit C . Inflammatory obstruction of the olfactory clefts and olfactory loss in humans: a new syndrome?. Chem Senses. 2007; 32(3):285-92. DOI: 10.1093/chemse/bjl057. View

Moein S, Hashemian S, Mansourafshar B, Khorram-Tousi A, Tabarsi P, Doty R . Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 2020; 10(8):944-950. PMC: 7262123. DOI: 10.1002/alr.22587. View

Pawelczyk M, Kowalski M . The Role of Human Parainfluenza Virus Infections in the Immunopathology of the Respiratory Tract. Curr Allergy Asthma Rep. 2017; 17(3):16. PMC: 7089069. DOI: 10.1007/s11882-017-0685-2. View

Calcagno N, Colombo E, Maranzano A, Pasquini J, Sarmiento I, Trogu F . Rising evidence for neurological involvement in COVID-19 pandemic. Neurol Sci. 2020; 41(6):1339-1341. PMC: 7214096. DOI: 10.1007/s10072-020-04447-w. View

10.

Suzuki M, Saito K, Min W, Vladau C, Toida K, Itoh H . Identification of viruses in patients with postviral olfactory dysfunction. Laryngoscope. 2007; 117(2):272-7. PMC: 7165544. DOI: 10.1097/01.mlg.0000249922.37381.1e. View

11.

Bagheri S, Asghari A, Farhadi M, Shamshiri A, Kabir A, Kamrava S . Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak in Iran. Med J Islam Repub Iran. 2020; 34:62. PMC: 7500422. DOI: 10.34171/mjiri.34.62. View

12.

Fujikura D, Miyazaki T . Programmed Cell Death in the Pathogenesis of Influenza. Int J Mol Sci. 2018; 19(7). PMC: 6073994. DOI: 10.3390/ijms19072065. View

13.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

14.

Paderno A, Schreiber A, Grammatica A, Raffetti E, Tomasoni M, Gualtieri T . Smell and taste alterations in COVID-19: a cross-sectional analysis of different cohorts. Int Forum Allergy Rhinol. 2020; 10(8):955-962. PMC: 7272886. DOI: 10.1002/alr.22610. View

15.

HAMRE D, PROCKNOW J . A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med. 1966; 121(1):190-3. DOI: 10.3181/00379727-121-30734. View

16.

Kaye R, Chang C, Kazahaya K, Brereton J, Denneny 3rd J . COVID-19 Anosmia Reporting Tool: Initial Findings. Otolaryngol Head Neck Surg. 2020; 163(1):132-134. DOI: 10.1177/0194599820922992. View

17.

Eliezer M, Hautefort C, Hamel A, Verillaud B, Herman P, Houdart E . Sudden and Complete Olfactory Loss of Function as a Possible Symptom of COVID-19. JAMA Otolaryngol Head Neck Surg. 2020; 146(7):674-675. DOI: 10.1001/jamaoto.2020.0832. View

18.

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q . Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77(6):683-690. PMC: 7149362. DOI: 10.1001/jamaneurol.2020.1127. View

19.

Mackay I, Arden K . MERS coronavirus: diagnostics, epidemiology and transmission. Virol J. 2015; 12:222. PMC: 4687373. DOI: 10.1186/s12985-015-0439-5. View

20.

Vaira L, Deiana G, Fois A, Pirina P, Madeddu G, De Vito A . Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases. Head Neck. 2020; 42(6):1252-1258. PMC: 7267244. DOI: 10.1002/hed.26204. View